Kilitch Drugs (India) Limited (KILITCH)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
157
-3.05(-1.91%)

Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrups, gripe water, and oral powders and liquids in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

163.45

TODAY'S LOW

155.65

52 WEEK HIGH

275.1

52 WEEK LOW

141.1

Major Holders

% of Shares Held by
All Insider

77.45%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

252.20 Cr.

ETERPRISE VALUE

221.21 Cr.

NO. OF SHARES

1.55 Cr.

BOOK VALUE

86.014

DIV. YIELD

0.5%

DEBT

17.56 Cr.

GROSS PROFIT

30.61 Cr.

CASH

48.74 Cr.

REVENUE

97.55 Cr.

REVENUE/SHARE

62.838

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments-27.20 Lakhs31.03 Lakhs3.85 Cr.-1.23 Cr.
Change To Liabilities46.56 Cr.2.84 Cr.-3.19 Cr.2.37 Cr.
Total cashflows from Investing Activities-37.56 Cr.-10.45 Cr.-13.97 Cr.-4.45 Cr.
Net Borrowings2.19 Cr.3.15 Cr.8.53 Cr.23.66 Lakhs
Total Cash from Financing Activities1.61 Cr.84.95 Lakhs16.85 Cr.5.50 Cr.
Other Liabilities-1.11 Cr.-1.18 Cr.41.14 Lakhs-83.28 Lakhs
Total Assets6.04 Lakhs7.90 Lakhs7.04 Cr.2.95 Cr.
Net Income3.67 Cr.84.20 Lakhs3.82 Cr.5.15 Cr.
Change in Cash9.70 Cr.-5.14 Cr.3.16 Cr.2.47 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities45.65 Cr.4.46 Cr.29.09 Lakhs1.42 Cr.
Depreciation1.14 Cr.1.15 Cr.1.19 Cr.1.19 Cr.
Other Cashflows from Investing Activities-99.93 Lakhs-26.49 Lakhs1.19 Cr.26.91 Lakhs
Dividends Paid0-1.79 Cr.-95.04 Lakhs-4.08 Lakhs
Change to Inventory1.97 Cr.-84.09 Lakhs-1.91 Cr.-20.12 Lakhs
Change to Account Receivables-8.66 Cr.5.51 Cr.-1.28 Cr.-8.04 Cr.
Other Cashflows from Financing Activities-64.08 Lakhs-59.42 Lakhs2.22 Cr.2.36 Cr.
Change to Net Income2.09 Cr.-3.86 Cr.1.23 Cr.1.75 Cr.
Capital Expenditures-36.29 Cr.-10.49 Cr.-19.02 Cr.-3.48 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax5.11 Cr.1.60 Cr.8.58 Cr.6.11 Cr.
Minority Interest2.35 Cr.2.21 Cr.2.09 Cr.73.13 Lakhs
Net Income4.13 Cr.-84.38 Lakhs6.86 Cr.4.51 Cr.
Selling General Administrative10.40 Cr.11.36 Cr.12.12 Cr.7.69 Cr.
Gross Profit30.61 Cr.23.54 Cr.33.47 Cr.24.25 Cr.
Ebit4.13 Cr.-84.38 Lakhs6.86 Cr.4.51 Cr.
Operating Income4.13 Cr.-84.38 Lakhs6.86 Cr.4.51 Cr.
Other Operating Expenses14.92 Cr.11.87 Cr.9.46 Cr.10.84 Cr.
Interest Expense-75.44 Lakhs-71.59 Lakhs-37.91 Lakhs-37.91 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense1.35 Cr.76.53 Lakhs4.75 Cr.96.03 Lakhs
Total Revenue68.52 Cr.53.32 Cr.82.48 Cr.51.01 Cr.
Total Operating Expenses64.38 Cr.54.16 Cr.75.62 Cr.46.49 Cr.
Cost of Revenue37.91 Cr.29.77 Cr.49.01 Cr.26.75 Cr.
Total Other Income Expense Net98.55 Lakhs2.45 Cr.1.71 Cr.1.59 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.3.76 Cr.84.20 Lakhs3.82 Cr.5.15 Cr.
Net Income Applicable to Common Shares3.67 Cr.84.20 Lakhs3.82 Cr.5.15 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets15.40 Lakhs5.01 Lakhs2.89 Lakhs2.35 Lakhs
Capital Surplus38.32 Cr.38.32 Cr.38.32 Cr.30.23 Cr.
Total Liabilities73.69 Cr.22.36 Cr.20.50 Cr.14.91 Cr.
Stock Holder Equity127.12 Cr.118.25 Cr.121.05 Cr.112.02 Cr.
Minority Interest2.35 Cr.2.21 Cr.2.09 Cr.73.13 Lakhs
Other Liabilities3.22 Cr.74.91 Lakhs4.29 Cr.4.95 Cr.
Total Assets203.17 Cr.142.83 Cr.143.66 Cr.127.67 Cr.
Common Stock15.49 Cr.15.43 Cr.15.35 Cr.13.73 Cr.
Retained Earnings67.61 Cr.63.26 Cr.63.35 Cr.60.44 Cr.
Other Liabilities38.06 Lakhs38.80 Lakhs41.34 Lakhs0
Good Will21.90 Cr.22.74 Cr.23.59 Cr.25.13 Cr.
Treasury Stock5.69 Cr.1.22 Cr.4.02 Cr.7.61 Cr.
Other Assets1.72 Cr.1.32 Cr.1.37 Cr.1.76 Cr.
Cash12.50 Cr.2.79 Cr.7.94 Cr.4.77 Cr.
Current Liabilities73.31 Cr.21.97 Cr.20.09 Cr.14.91 Cr.
Long Term Asset Charges1.27 Cr.96.62 Lakhs1.03 Cr.1.55 Cr.
Short Long Term Debt0000
Other Stockholder Equity5.69 Cr.1.22 Cr.4.02 Cr.7.61 Cr.
Property Plant Equipment73.38 Cr.38.33 Cr.28.76 Cr.10.98 Cr.
Total Cur. Assets80.36 Cr.55.78 Cr.64.87 Cr.62.98 Cr.
Long Term Investments25.64 Cr.24.58 Cr.25.01 Cr.26.78 Cr.
Net Tangible Assets105.06 Cr.95.45 Cr.97.43 Cr.86.86 Cr.
Short Term Investments36.40 Cr.27.81 Cr.28.41 Cr.30.29 Cr.
Net Receivables22.93 Cr.15.88 Cr.19.54 Cr.21.01 Cr.
Long Term Debt0000
Inventory3.58 Cr.5.55 Cr.4.71 Cr.2.79 Cr.
Accounts Payable53.65 Cr.7.10 Cr.4.34 Cr.7.71 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account